ANDA 83135, held by Gd Searle LLC. Lidocaine Hydrochloride.
As of Nov 16, 2026, ANDA 83135 (Lidocaine Hydrochloride), held by Gd Searle LLC, was not approved, with 2 approved supplements and 0 published complete response letters.
| Lidocaine Hydrochloride1% · injectable;injection | Lidocaine Hydrochloride | Discontinued |
| Lidocaine Hydrochloride2% · injectable;injection | Lidocaine Hydrochloride | Discontinued |
| Sep 24, 1982 | Supplement 5Manufacturing | Approved | None posted |
| Aug 9, 1982 | Supplement 3Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters